Element Squared’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Element Squared's REGN Position: Q2 2026 in Review
Element Squared increased its Regeneron Pharmaceuticals (REGN) stake by 5% in Q2 2026, buying an estimated $100K and bringing the position to 3,083 shares worth $1.92M. The position accounts for 0.96% of the portfolio, ranked #33.
Element Squared first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.27M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Element Squared held 3,083 shares of Regeneron Pharmaceuticals worth $1.92M as of Q2 2026.
- Element Squared bought 147 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $100K.
- Regeneron Pharmaceuticals made up 0.96% of Element Squared's portfolio in Q2 2026, its #33 holding.
- Element Squared first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Element Squared's Regeneron Pharmaceuticals position peaked at $2.27M in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Element Squared's 13F filing for Q2 2026, filed 28 Jul 2026.